Jennifer Ruddock | Head of Investor Relations |
Howard Robin | President & Chief Executive Officer |
Gil Labrucherie | Chief Operating Officer & Chief Financial Officer |
Jonathan Zalevsky | Head of Research & Development |
Chris Shibutani | Cowen |
Jessica Fye | JPMorgan |
Tyler Van Buren | Piper Jaffray |
Alex Lim | Mizuho |
George Farmer | BMO Capital Markets |
Gobind Singh | BMO Capital Markets |
Andy Hsieh | William Blair |
Daina Graybosch | SVB Leerink |
Ladies and gentlemen, thank you for standing by. And welcome to the Nektar Therapeutics Third Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference may be recorded.